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Abstract  
Background 
The antiepileptic drugs carbamazepine and gabapentin are efective in treating 
neuropathic pain and trigeminal neuralgia. In the present study, to analyze the efects of 
carbamazepine and gabapentin on neuronal excitation in the spinal trigeminal 
subnucleus caudalis (Sp5c) in the medula oblongata, we recorded temporal changes in 
nociceptive aferent activity in the Sp5c of trigeminal nerve-atached brainstem slices of 
neonatal rats using a voltage-sensitive dye imaging technique. 
Results 
Electrical stimulation of the trigeminal nerve rootlet evoked changes in the fluorescence 
intensity of dye in the Sp5c. The optical signals were composed of two phases, a fast 
component with a sharp peak folowed by a long-lasting component with a period of 
more than 500 ms. This evoked excitation was not influenced by administration of 
carbamazepine (10, 100 and 1000 µM) or gabapentin (1 and 10 µM), but was increased 
by administration of 100 µM gabapentin. This evoked excitation was increased further 
in low Mg
2+
 (0.8 mM) conditions, and this efect of low Mg
2+
 concentration was 
antagonized by 30 µM DL-2-amino-5-phosphonopentanoic acid (AP5), a 
4 
N-methyl-D-aspartate (NMDA) receptor blocker. The increased excitation in low Mg
2+
 
conditions was also antagonized by carbamazepine (1000 µM) and gabapentin 
(100 µM). 
Conclusions 
Carbamazepine and gabapentin did not decrease electricaly evoked excitation in the 
Sp5c in control conditions. Further excitation in low Mg
2+
 conditions was antagonized 
by the NMDA receptor blocker AP5. Carbamazepine and gabapentin had similar efects 
to AP5 on evoked excitation in the Sp5c in low Mg
2+
 conditions. Thus, we concluded 
that carbamazepine and gabapentin may act by blocking NMDA receptors in the Sp5c, 
which contributes to its anti-hypersensitivity in neuropathic pain. 
Keywords 
Carbamazepine, Gabapentin, Rat brainstem, Spinal trigeminal nucleus, 
Voltage-sensitive dye imaging 
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Background 
The antiepileptic agents carbamazepine and gabapentin are efective against 
neuropathic pain and trigeminal neuralgia [1, 2]. However, the action of these 
antiepileptic drugs on neuronal activity in the brain may not be simple. A large body of 
evidence indicates that carbamazepine may interact with diferent types of ion channels 
and synaptic transmission [3, 4]. The molecular targets for ion channels have generaly 
been voltage-gated Na
+
 channels [5], Ca
2+
 channels [6] and K
+
 channels [7]. An 
increasing number of findings indicate that carbamazepine induces the inhibition of 
glutamate release [8], inhibition of an adenosine receptor [9] and modulation of 
neuromodulator levels, such as those of serotonin, dopamin and cyclic adenosine 
monophosphate (AMP) [3]. In addition, the efects of gabapentin on neural activity are 
not explained by a single mechanism [10, 11]. Although gabapentin is a structural 
analogue of γ amino-butyric acid (GABA), it has no afinity for GABA receptors. The 
main target of gabapentin is synaptic transmission, where it inhibits voltage-gated Ca
2+
 
channels in the presynaptic membrane, which inhibits the release of glutamate and 
substance P [12]. Recent evidence suggests that other actions of gabapentin include 
inhibition of glutamatergic N-methyl-D-aspartate (NMDA) receptors [13] and an 
increase in GABA release [14]. 
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To study the neural mechanisms of trigeminal neuralgia, trigeminal nerve-atached 
brainstem preparations from neonatal rats are used [15,16]. In electrophysiological 
studies, activity-dependent neuronal hyperexcitability, so-caled central sensitization, 
has been reported in the spinal trigeminal subnucleus caudalis (Sp5c), which receives 
nociceptive information from the orofacial area. Furthermore, such studies have shown 
that NMDA receptors contribute substantialy to polysynaptic transmission in the Sp5c 
and to long-term potentiation. 
To analyze the spatial dynamics of neuronal excitation propagation in the Sp5c, it 
is possible to use optical imaging analysis and voltage-sensitive dyes [17, 18]. A 
previous study using trigeminal nerve-atached brainstem slices from postnatal rats 
showed that synaptic transmission via unmyelinated aferents in the Sp5c was mediated 
substantialy by NMDA receptors [19]. In the present study, we examined the efects of 
carbamazepine and gabapentin on excitability in the Sp5c of neonatal rats using an 
optical imaging technique. Furthermore, we confirmed the contribution of NMDA 
receptors to enhanced excitability in the Sp5c in low Mg
2+
 concentration conditions. 
 
Results 
 
Influence of carbamazepine on evoked excitation in the Sp5c  
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The influence of drug administration on evoked excitation was examined using 
trigeminal nerve-atached brainstem sagital slice preparations, as shown in Figure 1. 
Figure 2 shows the influence of carbamazepine at diferent concentrations (10, 100 or 
1000 µM) on evoked excitation in the Sp5c. During superfusion with mock 
cerebrospinal fluid (CSF) (Fig. 2A), the optical signals were composed of two phases, a 
fast component with a sharp peak folowed by a long-lasting component with a period 
of more than 500 ms. The time delay from stimulation to the peak of the first 
component was 36.8 ± 8.3 ms (n=6). The distance from the nerve rootlet to the Sp5c 
was approximately 4.0 mm. Therefore, the conduction velocity was approximately 
0.11 m/s. 
The intensity and time course of the optical signal did not alter significantly after 
switching to superfusion with 1000 µM carbamazepine-containing mock CSF (Fig. 2B). 
The left-hand panels in Figs. 2A and 2B show fluorescent signal images at 165 ms after 
electrical stimulation during superfusion with mock CSF and with 1000 µM 
carbamazepine-containing mock CSF, respectively. The right-hand panels in Figs. 2A 
and 2B show time-courses of fluorescent signal changes during superfusion with mock 
CSF (Fig. 2A) and with 1000 µM carbamazepine-containing CSF (Fig. 2B), 
respectively. When electrical stimulation was applied in the presence of 1000 µM 
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carbamazepine, the time-course of Sp5c excitement showed a sharp peak after 
stimulation folowed by a slow decline, similar to that in the control. To analyze signal 
amplitudes during superfusion with 10, 100 and 1000 µM carbamazepine, fluorescence 
signal amplitude was indicated as the percent amplitude of the control conditions. The 
peak amplitude of the first component seemed to decrease slightly to 96.0 ± 12.5% 
during superfusion of 1000 µM carbamazepine, but the diference was not significant 
(Fig. 2C). The peak amplitude of the first component was not afected by any 
concentration of carbamazepine (Fig. 2C). To evaluate the efect of carbamazepine on 
the long-lasting component, we measured the evoked signal at 165 ms and 385 ms after 
stimulation (Figs. 2D and 2E), but the signal amplitude of the long-lasting component 
was also unafected by carbamazepine (Figs. 2D and 2E).  
 
Influence of gabapentin on evoked excitation in the Sp5c 
The dose–response relationship of gabapentin with the evoked excitation was examined 
using trigeminal nerve-atached brainstem sagital slice preparations (Fig. 3). When 
electrical stimulation was applied in the presence of 1 or 10 µM gabapentin, the 
time-course of Sp5c excitement showed a sharp peak after stimulation folowed by a 
slow decline, similar to that in the control conditions. The signal amplitudes of the fast 
and long-lasting components were not affected by 1 or 10 µM gabapentin (Figs. 3C, 3D 
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and 3E). Of note, 100 µM gabapentin significantly increased the peak amplitude of the 
fast component to 178 ± 5.66% (p <0.01). Signal amplitudes at 165 ms and 385 ms after 
stimulation increased to 179 ± 23.5% (Fig. 3D) and 240 ± 31.2%, respectively (Fig. 3E). 
Thus, 100 µM gabapentin induced further excitation in the electrical trigeminal nerve 
root stimulation-induced excitement of the Sp5c. 
 
Influence of low Mg
2+ 
concentration and an NMDA antagonist on evoked 
excitation in the Sp5c 
The influence of low Mg
2+
 concentration (0.8 mM) on evoked excitation in the Sp5c 
was observed using trigeminal nerve-atached brainstem sagital slice preparations 
(Fig. 4). When electrical stimulation was applied during superfusion with low Mg
2+ 
concentration solution, the peak of the fast component after stimulation increased to 177 
± 30.6%. Furthermore, the signal amplitude at 165 ms and 385 ms after electrical 
stimulation increased markedly over 250% during superfusion with low Mg
2+
 
concentration solution (Fig. 4), suggesting that the low Mg
2+
 concentration increased 
electrical trigeminal nerve root stimulation-induced excitement in the Sp5c. The 
increase in the long-lasting component with low Mg
2+
 concentration treatment was 
greater than that of the fast component. A previous study performed by Takuma [19] 
showed that increased excitation in the Sp5c with low Mg
2+
 concentration treatment was 
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partialy antagonized by the NMDA antagonist AP5. We also examined additional 
superfusion with 30 µM AP5 in low Mg
2+
 conditions. Figure 4C showed that 
administration of AP5 atenuated the evoked excitement in the Sp5c and restored it to 
the control level. The peak amplitude was 126 ± 19.2% during superfusion with 30 µM 
AP5 in low Mg
2+
 conditions (Fig. 4D). The amplitude of the long-lasting component 
was also restored by additional superfusion with 30 µM AP5 in low Mg
2+
 conditions. 
The amplitudes at 165 ms and 385 ms after stimulation decreased to 104 ± 21.4% (Fig. 
4E) and 91.4 ± 31.5% (Fig. 4F), respectively. 
 
Influence of carbamazepine on evoked excitation in the Sp5c in low Mg
2+ 
conditions 
Figure 5 shows the efect of carbamazepine in low Mg
2+
 conditions on evoked 
excitation in the Sp5c. Superfusion with a low Mg
2+
 concentration solution potentiated 
the evoked excitation. The efect of these conditions on the long-lasting component 
(205± 67.3% at 165 ms and 237 ± 40.8% at 385 ms after stimulation) was more marked 
than that on the fast component (162 ± 63.8%). Additional administration of 1000 µM 
carbamazepine in low Mg
2+
 conditions atenuated the evoked excitation to the level of 
the control conditions (Fig. 5). The peak amplitude was 130 ± 40.2% during superfusion 
(Fig. 5D). The amplitude of the long-lasting component was also restored by additional 
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superfusion with carbamazepine in low Mg
2+
 conditions. The amplitudes at 165 ms and 
385 ms after stimulation decreased to 113 ± 58.5% (Fig. 5E) and 119 ± 60.7% (Fig. 5F), 
respectively. The efect of carbamazepine in low Mg
2+
 conditions was similar to that of 
AP5. 
 
Influence of gabapentin on evoked excitation in the Sp5c in low Mg
2+ 
conditions 
Figure 6 shows the efect of gabapentin on evoked excitation in the Sp5c in low Mg
2+
 
conditions. Superfusion with low Mg
2+
 concentration solution caused potentiation of the 
evoked excitation. The efect of low Mg
2+
 concentration solution on the long-lasting 
component (148 ± 14.5% at 165 ms and 186 ± 21.5% at 385 ms after stimulation) was 
more marked than that on the fast component (128 ± 23.0%). Additional administration 
of 100 µM gabapentin in low Mg
2+
 conditions atenuated the evoked excitation to the 
level of the control conditions (Fig. 6). The peak amplitude was 119 ± 22.2% during 
superfusion (Fig. 6D). The amplitude of the long-lasting component was also restored 
by additional superfusion with carbamazepine in low Mg
2+
 conditions. Amplitudes at 
165 ms and 385 ms after stimulation decreased to 97.8 ± 10.7% (Fig. 6E) and 115 ± 
12.4% (Fig. 6F), respectively. The efects of gabapentin in low Mg
2+
 conditions was 
similar to those of AP5 and carbamazepine.  
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Discussion 
Applying the voltage-sensitive dye imaging method with isolated neonatal rat brainstem 
slices alowed electrical trigeminal nerve stimulation-induced excitement of the Sp5c to 
be temporaly and spatialy visualized. Sole administration of carbamazepine and of low 
concentrations of gabapentin did not afect evoked excitation in the Sp5c, although 
administration of a high concentration of gabapentin emphasized the evoked excitation 
in the Sp5c. Superfusion with a low Mg
2+
 solution potentiated the evoked excitation. 
The efect of low Mg
2+
 conditions on the long-lasting component was more marked than 
that on the fast component. Additional administration of AP5, carbamazepine or 
gabapentin in low Mg
2+
 conditions atenuated the evoked excitation to the level of the 
control conditions, showing that the emphasized excitement by low Mg
2+
 concentration 
was antagonized by AP5, carbamazepine or gabapentin. 
Single-pulse stimulation of the trigeminal nerve rootlet induced an optical 
response in the Sp5c. The optical signals were composed of two phases, a fast 
component with a sharp peak folowed by a long-lasting component with a period of 
approximately 500 ms. These findings were consistent with those of Takuma [19], who 
found that the spatiotemporal properties of optical signals were corelated with those of 
the field potential recordings by using similar preparations to ours. The optical signal of 
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the fast component was eliminated by treatment with 
6-cyano-nitro-quinoxaline-2,3-dione (CNQX). The long-lasting component increased in 
amplitude in low Mg
2+
 conditions but was significantly reduced by AP5. In an 
electrophysiological study using whole-cel patch-clamp techniques, Onodera et al. [16] 
reported that stimulation of the mandibular nerve at 0.03 Hz evoked compound 
excitatory postsynaptic potentials (EPSPs) of neurons in the Sp5c. Compound potentials 
consistent with monosynaptic EPSPs, which had a high threshold and with polysynaptic 
EPSPs, was atenuated by high frequency (33–50 Hz) stimulation. In low Mg
2+
 
conditions, the fast monosynaptic EPSP component was abolished by simultaneous 
application of CNQX and AP5, and the slow polysynaptic EPSP was largely atenuated 
by application of AP5. In the present study, we confirmed the result that AP5 atenuated 
the fast component and largely atenuated the long-lasting component in low Mg
2+
 
conditions. The result that enhanced excitation in low Mg
2+
 conditions was atenuated 
by application of AP5 suggested that low Mg
2+
 conditions induced the activation of 
NMDA receptors in the secondary neurons of the Sp5c. Furthermore, we demonstrated 
that carbamazepine and gabapentin had similar efects to AP5 on evoked excitation in 
the Sp5c in low Mg
2+
 conditions. This result strongly suggested that carbamazepine and 
gabapentin act as antagonists of NMDA receptors. Therefore, blockage of NMDA 
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receptors of secondary neurons in the Sp5c may contribute to the clinical efectiveness 
of carbamazepine and gabapentin. 
Inhibition of ion channels and synaptic transmission have been reported as the 
pharmacological actions of carbamazepine on the nervous system (see Introduction). In 
control conditions, sole application of carbamazepine did not afect evoked excitement 
in the Sp5c, suggesting that carbamazepine did not modulate the normal transduction of 
action potential and synaptic transmission. When excessive activation of the NMDA 
receptor is induced in the pathophysiology of several neurological conditions, such as 
trigeminal neuropathic pain, application of carbamazepine was efective because of a 
block in the activation of NMDA receptors [20, 21]. 
Regarding the pharmacological action of gabapentin on the nervous system, the 
inhibition of active potential induction through binding to the α2δ subunit of 
voltage-dependent Ca
2+
 channels has been reported [22]. Because gabapentin has a high 
afinity for the α2δ subunit, it was considered to inhibit the release of neurotransmiters 
by inhibiting Ca
2+
 ion influx [11]. Gabapentin has also been shown to induce the 
modulation of other targets including NMDA receptors. In the present study, we 
suggested that the efective site of gabapentin was NMDA receptors in the Sp5c. 
One unanticipated finding was that sole application of 100 µM gabapentin 
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emphasized the evoked excitation in control conditions. Petrof et al. [14] reported that 
gabapentin increased GABA levels in the brains of epileptic patients. Densely packed 
GABAergic neurons in the Sp5c have been described previously [23, 24]. Because 
GABAergic transmission in various brain regions of immature animals is excitatory and 
inhibitory synaptic potentials appear relatively later in development [25], we should 
consider that not only non-GABAergic but also GABAergic interneurons in this region 
were excited. It may be possible that a high concentration of gabapentin induced GABA 
release, and GABA acts as an excitatory transmiter in the Sp5c. However, application 
of bicuculine further increased the evoked excitation after application of 100 µM 
gabapentin (unpublished data), suggesting that GABAergic transmission was inhibitory 
in our preparations. Therefore, the possibility that GABAergic transmission in the Sp5c 
is excitatory may be ruled out. To clarify the mechanisms of excitation by gabapentin, 
further studies are required. 
In the present study, we estimated the conduction velocity as approximately 
0.11 m/s for the peak of the fast component. This value was similar to the value 
(~0.18 m/s) calculated by previous optical measurements [19]. These values were slow 
compared with a previous electrophysiological method, in which the conduction 
velocity was calculated to be 0.37 m/s [16]. Conduction velocities obtained by optical 
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and electrophysiological studies fal into the range of that of C-fibers. On the other hand, 
trigeminal sensory neurons changed electrophysiological properties during early 
postnatal maturation. Cabanes et al. [26] showed that trigeminal ganglion neurons in 
neonatal mice had uniformly slow conduction velocities and separated according to 
their conduction velocity into Aδ and C neurons during the 3-week postnatal 
development period. Thus, it is dificult to show which axon type of a trigeminal nerve 
was mainly stimulated in the present study. 
In conclusion, antiepileptic drugs carbamazepine and gabapentin did not decrease 
electricaly evoked excitation in the Sp5c in control conditions. Further excitation in 
low Mg
2+
 conditions was atenuated by the NMDA receptor antagonist AP5. 
Carbamazepine and gabapentin had similar efects to AP5 on evoked excitation in the 
Sp5c in low Mg
2+
 conditions. Thus, we concluded that carbamazepine and gabapentin 
act by blocking NMDA receptors in the Sp5c, which contributes to its 
anti-hypersensitivity action in neuropathic pain and trigeminal neuralgia. 
 
Methods 
Preparations 
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Al procedures were conducted in accordance with the guidelines of the Uekusa Gakuen 
University Laboratory Animal
 
Care and Use Commitee. Data were obtained from 54 
neonatal Wistar rats (2–3 days old). The isolation of brainstem-spinal cord preparations 
has been described in detail previously [27]. In brief, rats were deeply anesthetized with 
diethyl ether and the brainstem was isolated in a dissecting chamber at room 
temperature. The chamber was filed with mock CSF equilibrated with a gas mixture 
(5% CO
2
 in O
2
; pH 7.4). The composition of the mock CSF was as folows (in mM): 
NaCl, 126; KCl, 5; CaCl
2
, 2; MgSO
4
, 2; NaH
2
PO
4
, 1.25; NaHCO
3
, 26 and glucose, 30. 
The cerebrum was quickly removed by transection at the upper border of the inferior 
coliculus. Each trunk of the bilateral trigeminal nerves that run through the craniobasal 
bone was isolated to a length of 1 mm, enabling it to be puled into a suction electrode. 
Subsequently, the trigeminal nerve-atached brainstem-spinal cord was cut caudaly at 
the level of the C3 roots (Fig. 1A). Furthermore, the isolated medula was sectioned 
sagitaly at 1–1.5 mm lateral from the midsagital plane with a handmade slicer (Fig. 
1B). The trigeminal nerve-atached brainstem sagital slice was placed in a recording 
chamber (volume 1.0 mL) with the medial side up and continuously superfused (flow 
4–6 mL/min) at 26°C with oxygenated mock CSF.  
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Voltage-sensitive dye imaging 
The voltage-sensitive dye imaging technique has been described in detail previously 
[28]. In brief, for staining, preparations were kept for 30 min in mock CSF containing 
the voltage-sensitive dye Di-4-ANEPPS (7.5 mg/mL in 0.1% DMSO, Molecular Probes, 
Eugene, Oregon, USA), before being kept for at least 30 min in normal mock CSF. 
After staining, excess dye was removed by superfusion of the preparation with dye-free 
solution. After 30 min of washing, optical imaging and data analysis were performed 
using a MiCAM02 hardware and software package (BrainVision, Tokyo, Japan). For 
optical imaging, we used a fixed-stage upright fluorescence microscope (Measurescope 
UM-2, Nikon, Tokyo, Japan) with a low magnification objective lens (XL Fluor 4×/340, 
Olympus, Tokyo, Japan) and a high-resolution MiCAM02 camera. 
To record the voltage-sensitive dye signals, we used light from a 150 W halogen 
lamp controled by an electromagnetic shuter (Oriel Instruments, Stratford, USA). 
Changes in fluorescence of the dye were detected by the camera through a 510–560 nm 
excitation filter, a dichroic miror, and a 590 nm absorption filter (MBE1405, Nikon). 
The camera captured images of 88 × 60 pixels, and the size of the area was 5.4 × 
3.7 mm. Optical signals from 3 × 3 pixels (approximately 0.03 mm
2
) were averaged and 
are showed in the images. 
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Total frame acquisition was set to 511. Sampling time was 2.2 ms/frame; therefore, the 
total recording time was 1124.2 ms. Neuronal activity was evoked by square pulse 
electrical stimuli (1.0 ms, 0.5–1.0 mA) delivered to the trigeminal nerve rootlet via a glass 
suction electrode. Acquisition was triggered by the electrical stimulus. The trigger signal 
was activated after one-quarter of the total recording time, corresponding to 284 ms 
after starting acquisition when we set the total acquisition time to 1124.2 ms. Signal 
amplitude was normalized using the dF/F method, where F is the total fluorescent signal 
and dF coresponds to the change in fluorescence observed folowing evoked 
modification of the membrane potential. To improve the signal-to-noise ratio, we 
averaged signals detected in 10 consecutive trials at 0.3 Hz. To analyze the intensity of 
the signals, we measured the peak amplitude (at 30–40 ms after stimulation) and 
amplitudes at 40% (at 165 ms after stimulation) and at 60% (at 385 ms after 
stimulation) of the total recording time (1124.2 ms). Measuring points at 165 ms and 
385 ms after stimulation were selected arbitrarily. 
 
Drug administration 
Carbamazepine (Sigma Aldrich, Saint Louis, MO, USA) was added to perfused mock 
CSF at 10, 100 and 1000 µM. Gabapentin (Sigma Aldrich) was added to perfused mock 
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CSF at 1.0, 10 and 100 µM. NMDA receptor antagonist 
DL-2-amino-5-phosphonopentanoic acid (AP5, Sigma Aldrich) was added to perfused 
mock CSF at 30 µM. These concentrations were determined from preliminary 
experiments and previous studies [16, 29]. Optical records using electrical stimulation 
were taken 20 min after the start of superfusion with control mock CSF and were taken 
20 min after switching to drug-containing mock CSF. To induce activation of the 
NMDA receptor, we used low Mg
2+
 concentration solution (in mM): NaCl, 126; KCl, 5; 
CaCl
2
, 2.6; MgSO
4
, 0.8; NaH
2
PO
4
, 1.25; NaHCO
3
, 26 and glucose, 30. In these series of 
experiments, optical records using electrical stimulation were taken 20 min after the 
start of superfusion with control mock CSF and were taken 20 min after switching to 
low Mg
2+
 concentration solution, and then, taken 20 min after switching to low Mg
2+
 
solution containing 30 µM AP5, 1000 µM carbamazepine or 100 µM gabapentin. 
 
Data analysis 
Optical signal amplitudes obtained before superfusion with mock CSF containing drugs 
was defined as the control value. The level of statistical significance for the diference 
between the mean value of each variable obtained during application of different 
concentrations of drug was conducted by ANOVA folowed by pair-wise comparisons 
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using the Tukey-Kramer method for multiple comparisons as indicated. Al statistical 
analyses were conducted using Statcel (OMS publisher, Japan). Al values were reported 
as mean ± SD, and al P values < 0.05 were considered significant. 
 
Competing interests 
The authors declared that they have no competing interests. 
 
Authors' contributions 
AM and HA caried out experiments, colected and analyzed data, and drafted the 
manuscript. AM and HA contributed equaly to this study. YH caried out experiments 
and conducted the study. SS and KY helped design and conduct the study, and drafted 
the manuscript. TS and NU caried out experiments and colected and analyzed data. SK 
designed and supervised this study, explained the data, and drafted the manuscript. Al 
authors read and approved the final manuscript. 
Acknowledgements  
This work was supported by JSPS KAKENHI grant numbers 23590719, 26460704, by 
the Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for 
22 
Private Schools of Japan, and by the Science Research Fund of the Uekusa Gakuen 
University. 
 
Author details 
1
 Division of Anesthesiology, Department of Clinical Care Medicine, Kanagawa Dental 
Colege, Yokosuka City, Kanagawa 238-8580, Japan. 
2
 Department of Anesthesiology, 
Kitasato University School of Medicine, Sagamihara City, Kanagawa 252-0375, Japan. 
3
 Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, 
Ibaraki-ken 300-0394, Japan 
4
Faculty of Health Sciences, Uekusa Gakuen University, 
Ogura-cho, Wakaba-ku, Chiba City 264-0007, Japan 
 
References 
1. Lemos L, Alegria C, Oliveira J, Machado A, Oliveira P, Almeida A: 
Pharmacological versus decompression approaches for treatment of trigeminal 
neuralgia: clinical outcomes and direct costs. J Pain Res 2011, 4:233-244. 
2. Lemos L, Fontes R, Frores S, Oliveira P, Almeida A: Effectiveness of the 
association between carbamazepine and peripheral analgesic block with 
ropivacaine tor the treatment of trigeminal neuralgia. J Pain Res 2010, 
23 
3:201-212. 
3. Worley PF, Baraban JM.: Site of anticonvulsant action on sodium channels: 
autoradiographic and electrophysiological studies in rat brain. Proc Natl Acad 
Sci U S A. 1987, 84:3051-3055. 
4. Ambrósio AF, Soares-Da-Silva P, Carvalho CM, Carvalho AP: Mechanisms of 
action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and 
BIA 2-024. Neurochem Res 2002, 27:121-130. 
5. Uemura Y, Fujita T, Ohtsubo S, Hirakawa N, Sakaguchi Y, Kumamoto E: Efects of 
various antiepileptics used to aleviate neuropathic pain on compound action 
potential in frog sciatic nerves: comparison with those of local anesthetics. 
Biomed Res Int 2014, Article ID 540238, 9 pages 
6. Todorovic SM, Lingle CJ: Pharmacological properties of T-type Ca2+ current in 
adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. 
Neurophysiol 1998, 79:240-252. 
7. Zona C, Tancredi V, Palma E, Pirone GC, Avoli M: Potassium currents in rat 
cortical neurons in culture are enhanced by the antiepileptic drug 
carbamazepine. Can J Physiol Pharmacol 1990, 68:545-547. 
8. Okada M, Kawata Y, Mizuno K, Wada K, Kondo T, Kaneko S: Interaction between 
24 
Ca
2+
, K
+
, carbamazepine and zonisamide on hippocampal extracelular 
glutamate monitored with a microdialysis electrode. Br J Pharmacol 1998, 
124:1277-1285. 
9. Biber K, Fiebich BL, Gebicke-Härter P, van Calker D: Carbamazepine-induced 
upregulation of adenosine A1-receptors in astrocyte cultures affects coupling to 
the phosphoinositol signaling pathway. Neuropsychopharmacology 1999, 
20:271-278. 
10. Cheng JK, Chiou LC: Mechanisms of the antinociceptive action of gabapentin. J 
Pharmacol Sci 2006, 100:471-486. 
11. Kukkar A1, Bali A, Singh N, Jaggi AS: Implications and mechanism of action of 
gabapentin in neuropathic pain. Arch Pharm Res 2013, 36:237-251. 
12. Suton KG, Martin DJ, Pinnock RD, Lee K, Scot RH: Gabapentin inhibits 
high-threshold calcium channel currents in cultured rat dorsal root ganglion 
neurons. Br J Pharmacol 2002, 135: 257-265. 
13. Kim YS, Chang HK, Lee JW, Sung YH, Kim SE, Shin MS, Yi JW, Park JH, Kim H, 
Kim CJ: Protective effect of gabapentin on N-methyl-D-aspartate-induced 
excitotoxicity in rat hippocampal CA1 neurons. J Pharmacol Sci 2009, 109: 
144-147.  
25 
14. Petrof OA, Hyder F, Rothman DL, Matson RH: Efects of gabapentin on brain 
GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia 2000, 
41:675-680. 
15. Hamba M, Onodera K, Takahashi T: Long-term potentiation of primary afferent 
neurotransmission at trigeminal synapses of juvenile rats. Eur J Neurosci 2000, 
12:1128-1134. 
16. Onodera K, Hamba M, Takahashi T: Primary afferent synaptic responses 
recorded from trigeminal caudal neurons in a mandibular nerve-brainstem 
preparation of neonatal rats. J Physiol 2000, 524:503-512.  
17. Seo K, Fujiwara N, Takeuchi K, Maeda T, Someya G: Optical imaging of 
excitation propagation evoked by stimulation to the trigeminal caudalis. 
Neuroreport 2001, 12:3985-3988.  
18. Seo K, Fujiwara N, Takeuchi K, Maeda T, Someya G: Repetitive afferent 
stimulation propagates excitation in the trigeminal caudalis. Neuroreport 2003, 
14:1321-1325. 
19. Takuma S: Efect of neonatal capsaicin treatment on neural activity in the 
medulary dorsal horn of neonatal rats evoked by electrical stimulation to the 
trigeminal afferents: an optical, electrophysiological, and quantitative study. 
26 
Brain Res 2001, 906:1-12. 
20. Landmark CJ: Targets for antiepileptic drugs in the synapse. Med Sci Monit 2007, 
13: RA1-7. 
21. Hahm TS1, Ahn HJ, Ryu S, Gwak MS, Choi SJ, Kim JK, Yu JM: Combined 
carbamazepine and pregabalin therapy in a rat model of neuropathic pain. Br J 
Anaesth 2012, 109:968-974.  
22. D’Melo R, Dickenson AH: Spinal cord mechanisms of pain. Br J Anaesth 2008, 
101:8–16. 
23. Kuwana S, Tsunekawa N, Yanagawa Y, Okada Y, Kuribayashi J, Obata K:  
Electrophysiological and morphological characteristics of GABAergic 
respiratory neurons in the mouse pre-Bötzinger complex. Eur J Neurosci 2006, 
23:667-674. 
24. Viggiano A, Monda M, Viggiano A, Chiefari M, Aurilio C, De Luca B: Evidence 
that GABAergic neurons in the spinal trigeminal nucleus are involved in the 
transmission of inflammatory pain in the rat: a microdialysis and 
pharmacological study. Eur J Pharmacol 2004, 496:87-92. 
25. Ben-Ari Y: The GABA excitatory/inhibitory developmental sequence. 
Neuroscience 2014, 279:187-219. 
27 
26. Cabanes C, López de Armentia M, Viana F, Belmonte C: Postnatal changes in 
membrane properties of mice trigeminal ganglion neurons. J Neurophysiol 2002, 
87:2398-2407. 
27. Kuwana S, Okada Y, Natsui T: Effects of extracelular calcium and magnesium 
on central respiratory control in the brainstem-spinal cord of neonatal rat. 
Brain Res 1998, 786: 194-204. 
28. Okada Y, Chen Z, Yoshida H, Kuwana S, Jiang W, Maruiwa H: Optical recording 
of the neuronal activity in the brainstem-spinal cord: application of a 
voltage-sensitive dye. Adv Exp Med Biol 2001, 499:113-118. 
29. D’Melo R, Dickenson AH: Spinal cord mechanisms of pain. Br J Anaesth 2008, 
101:8–16. 
  
28 
Figure legends 
Figure 1 Preparations used for membrane potential imaging 
A: Isolated trigeminal nerve-brainstem preparation. The dorsal side is shown at the front, 
and the sagital sectional surface is shown by hatching. B: Trigeminal nerve-atached 
brainstem sagital slice preparation. The preparation was placed with the sagital 
sectional surface upwards for measurement. Electric stimulation was applied by sucking 
the trigeminal nerve root with a suction electrode for al preparations. 
Sp5c: Spinal trigeminal subnucleus caudalis, V rootlet: Trigeminal nerve rootlet. 
 
Figure 2 Efect of carbamazepine on evoked excitation in the Sp5c 
A: Recording made during superfusion with control mock CSF. The left panels 
represent neural activity, which is indicated as change in fluorescence intensity using 
pseudocolor. The right panel shows the time course of the signal change and time of 
electrical stimulation. Optical image in the left panel shows 165 ms after stimulation, as 
indicated by the vertical doted line in the right panel. Two horizontal lines in the image 
are the anchors for slice preparation. B: Recording made during superfusion with mock 
CSF containing 1000 µM carbamazepine. C: Peak amplitudes of evoked excitation in 
the Sp5c (indicated by arrows in the right panels of A and B) were measured during 
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superfusion with 10, 100 and 1000 µM carbamazepine. D: Fluorescence signal 
amplitudes at 165 ms after stimulation (indicated by arows in the right panels of A and 
B) were measured during superfusion with 10, 100 and 1000 µM carbamazepine. E: 
Fluorescence signal amplitudes at 385 ms after stimulation (indicated by arrows in the 
right panels of A and B) were measured during superfusion with 10, 100 and 1000 µM 
carbamazepine. In each graph, fluorescence signal amplitude is indicated as the percent 
amplitude of the control value during superfusion with control mock CSF. Data of each 
concentration were obtained from six preparations and are presented as mean ± SD. 
Carbamazepine did not induce significant changes in evoked excitation in the Sp5c. NS: 
not significant. 
 
Figure 3 Efect of gabapentin on evoked excitation in the Sp5c  
A: Recording made during superfusion with control mock CSF. The left panels 
represent neural activity, which is indicated as changes in fluorescence intensity using 
pseudocolor. The right panel shows the time course of the signal change and time of 
electrical stimulation. Optical image in the left panel shows 165 ms after stimulation, as 
indicated by the vertical doted line in the right panel. Two horizontal lines in the image 
are the anchors for slice preparation. B: Recording made during superfusion with mock 
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CSF containing 100 µM gabapentin. C: Peak amplitudes of evoked excitation in the 
Sp5c (indicated by arows in the right panels of A and B) were measured during 
superfusion with 1, 10 and 100 µM gabapentin. D: Fluorescence signal amplitudes at 
165 ms after stimulation (indicated by arows in the right panels of A and B) were 
measured during superfusion with 1, 10 and 100 µM gabapentin. E: Fluorescence signal 
amplitudes at 385 ms after stimulation (indicated by arows in the right panels of A and 
B) were measured during superfusion with 1, 10 and 100 µM gabapentin. In each graph, 
fluorescence signal amplitude is indicated as the percent amplitude of the control value 
during superfusion with control mock CSF. Data of each concentration were obtained 
from six preparations and are presented as mean ±SD. Administration of 1 and 10 µM 
gabapentin did not induce significant changes in evoked excitation in the Sp5c, but 100 
µM gabapentin emphasized the evoked excitation. ** P<0.01; NS not significant.  
 
Figure 4 Efect of low Mg
2+
 concentration solution and AP5 on evoked 
excitation in the Sp5c 
A: Recording made during superfusion with control mock CSF. B: Recording made 
during superfusion with low Mg
2+
 concentration (0.8 mM) solution. C: Recording made 
during superfusion with low Mg
2+
 solution containing 30 µM AP5. D: Peak amplitudes 
of evoked excitation in the Sp5c (indicated by arows in the right panels of A, B and C) 
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were measured during superfusion with control solution, with low Mg
2+
 solution and 
with low Mg
2+
 solution containing 30 µM AP5. E: Fluorescence signal amplitudes at 
165 ms after stimulation (indicated by arows in the right panels of A, B and C) were 
measured during superfusion with control solution, with low Mg
2+
 solution, and with 
low Mg
2+
 solution containing 30 µM AP5. F: Fluorescence signal amplitudes at 385 ms 
after stimulation (indicated by arows in the right panels of A, B and C) were measured 
during superfusion with control solution, with low Mg
2+
 solution, and with low Mg
2+
 
solution containing 30 µM AP5. In each graph, fluorescence signal amplitude is 
indicated as the percent amplitude of the control value during superfusion with control 
mock CSF. Data were obtained from six preparations and are presented as mean ±SD. 
Low Mg
2+
 solution induced significant increases in evoked excitation in the Sp5c, but 
this increase was antagonized by additional administration of 30 µM AP5. * P<0.05; ** 
P<0.01; NS not significant.  
 
Figure 5 Efect of carbamazepine in low Mg
2+
 conditions on evoked 
excitation in the Sp5c 
A: Recording made during superfusion with control mock CSF. B: Recording made 
during superfusion with low Mg
2+
 concentration (0.8 mM) solution. C: Recording made 
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during superfusion with low Mg
2+
 solution containing 1000 µM carbamazepine. D: 
Peak amplitudes of evoked excitation in the Sp5c (indicated by arows in the right 
panels of A, B and C) were measured during superfusion with control solution, with low 
Mg
2+
 solution and with low Mg
2+
 solution containing 1000 µM carbamazepine. E: 
Fluorescence signal amplitudes at 165 ms after stimulation (indicated by arrows in the 
right panels of A, B and C) were measured during superfusion with control solution, 
with low Mg
2+
 solution, and with low Mg
2+
 solution containing 1000 µM 
carbamazepine. F: Fluorescence signal amplitudes at 385 ms after stimulation  
(indicated by arows in the right panels of A, B and C) were measured during 
superfusion with control solution, with low Mg
2+
 solution and with low Mg
2+
 solution 
containing 1000 µM carbamazepine. In each graph, fluorescence signal amplitude is 
indicated as the percent amplitude of the control value during superfusion with control 
mock CSF. Data were obtained from six preparations and are presented as mean ±SD. 
Low Mg
2+
 solution induced significant increases in evoked excitation in the Sp5c, but 
this increase was antagonized by additional administration of 1000 µM carbamazepine. 
* P<0.05; ** P<0.01; NS not significant. 
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Figure 6 Efect of gabapentin in low Mg
2+
 conditions on evoked excitation 
in the Sp5c 
A: Recording made during superfusion with control mock CSF. B: Recording made 
during superfusion with low Mg
2+
 concentration (0.8 mM) solution. C: Recording made 
during superfusion with low Mg
2+
 solution containing 100 µM gabapentin. D: Peak 
amplitudes of evoked excitation in the Sp5c (indicated by arows in the right panels of 
A, B and C) were measured during superfusion with control solution, with low Mg
2+
 
solution and with low Mg
2+
 solution containing 100 µM gabapentin. E: Fluorescence 
signal amplitudes at 165 ms after stimulation (indicated by arows in the right panels of 
A, B and C) were measured during superfusion with control solution, with low Mg
2+
 
solution, and with low Mg
2+
 solution containing 100 µM gabapentin. F: Fluorescence 
signal amplitudes at 385 ms after stimulation (indicated by arows in the right panels of 
A, B and C) were measured during superfusion with control solution, with low Mg
2+
 
solution and with low Mg
2+
 solution containing 100 µM gabapentin. In each graph, 
fluorescence signal amplitude is indicated as the percent amplitude of the control value 
during superfusion with control mock CSF. Data were obtained from six preparations 
and are presented as mean ± SD. Low Mg
2+
 solution induced significant increases in 
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evoked excitation in the Sp5c, but this increase was antagonized by additional 
administration of 100 µM gabapentin. * P<0.05; ** P<0.01; NS not significant.  
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